X

Health Care

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2020 Earnings Call Transcript

Aurinia Pharmaceuticals Inc  (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate…

10x Genomics, Inc. (TXG) Q2 2020 Earnings Call Transcript

10x Genomics, Inc.  (NASDAQ: TXG) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations…

Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021

Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020…

Trxade launches integrated COVID-19 risk assessment tool for corporate clients

Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such…

Sage Therapeutics Inc (SAGE) Q2 2020 Earnings Call Transcript

Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle -- Senior Director of Investor…

Tilray Inc. (TLRY) Q2 2020 Earnings Call Transcript

Tilray Inc.  (NASDAQ: TLRY) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive…

Novavax Inc. (NVAX) Q2 2020 Earnings Call Transcript

Novavax Inc  (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor -- Senior Vice President, Investor Relations…

Novavax (NVAX) tops Q2 2020 bottom line targets, misses revenue views

Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue…

Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead

The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While…

Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript

Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran -- Vice President-Investor Relations Michael…

Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript

Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank -- Vice President of Investor Relations…

Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and…

Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript

Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations…

Metlife Inc. (MET) Q2 2020 Earnings Conference Call Transcript

Metlife Inc. (NYSE: MET) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: John Hall -- Head of Investor Relations Michel…

Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings

https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better…

Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript

Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor…

Humana Inc (HUM) Q2 2020 Earnings Call Transcript

Humana Inc (NYSE: HUM) Q2 2020 earnings call dated August 5, 2020 Corporate Participants: Amy Smith -- Vice President of Investor Relations…

Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript

Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane…

CVS Health Corp. (CVS) Q2 2020 Earnings Call Transcript

CVS Health Corp. (NYSE: CVS) Q2 2020 earrings call dated Aug. 05, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President…

Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook

Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street's revenue targets. The drug manufacturer reported adjusted…

Moderna impresses on the financial side as well in Q2

Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past…